Mechanisms of macrolide resistance in clinical pneumococcal isolates in France

被引：42

作者：

Fitoussi, F

Doit, C

Geslin, P

Brahimi, N

Bingen, E

机构：

[1] Hop Robert Debre, Microbiol Serv, F-75019 Paris, France

[2] Ctr Hosp Creteil, Ctr Natl Reference Pneumocoques, F-94010 Creteil, France

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2001年 / 45卷 / 02期

关键词：

D O I：

10.1128/AAC.45.2.636-638.2001

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The genetic basis of macrolide resistance was investigated in a collection of 48 genotypically unrelated clinical isolates of Streptococcus pneumoniae obtained between 1987 and 1997 in France. All strains were resistant to erythromycin, clindamycin, and streptogramin B, exhibiting a macrolide-lineosamide-streptogramin B resistance phenotype, and harbored the erm(B) gene. None of the strains carried the mef(A) or erm(A) subclass erm(TR) gene.

引用

收藏

页码：636 / 638

页数：3

相关论文

共 25 条

[1] Evolving resistance patterns of Streptococcus pneumoniae:: A link with long-acting macrolide consumption? [J].

Baquero, F .

JOURNAL OF CHEMOTHERAPY, 1999, 11 :35-43

[2] Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain:: Results of a 1-year (1996-1997) multicenter surveillance study [J].

Baquero, F ;

García-Rodríguez, JA ;

de Lomas, JG ;

Aguilar, L .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (02) :357-359

[3] Comparative in vitro activities of linezolid, quinupristin-dalfopristin, moxifloxacin, and trovafloxacin against erythromycin-susceptible and -resistant streptococci [J].

Betriu, C ;

Redondo, M ;

Palau, ML ;

Sánchez, A ;

Gómez, M ;

Culebras, E ;

Boloix, A ;

Picazo, JJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (07) :1838-1841

[4] Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients [J].

Bingen, E ;

Fitoussi, F ;

Doit, C ;

Cohen, R ;

Tanna, A ;

George, R ;

Loukil, C ;

Brahimi, N ;

Le Thomas, I ;

Deforche, D .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (06) :1453-1457

[5] Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes [J].

Clancy, J ;

Petitpas, J ;

DibHajj, F ;

Yuan, W ;

Cronan, M ;

Kamath, AV ;

Bergeron, J ;

Retsema, JA .

MOLECULAR MICROBIOLOGY, 1996, 22 (05) :867-879

[6] CHARACTERIZATION OF A PLASMID DETERMINING RESISTANCE TO ERYTHROMYCIN, LINCOMYCIN, AND VERNAMYCIN B ALPHA IN A STRAIN OF STREPTOCOCCUS-PYOGENES [J].

CLEWELL, DB ;

FRANKE, AE .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1974, 5 (05) :534-537

[7] Antipneumococcal activity of ABT-773 compared to those of 10 other agents [J].

Davies, TA ;

Ednie, LM ;

Hoellman, DM ;

Pankuch, GA ;

Jacobs, MR ;

Appelbaum, PC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (07) :1894-1899

[8] Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997-98 [J].

Doern, GV ;

Brueggemann, AB ;

Huynh, H ;

Wingert, E ;

Rhomberg, P .

EMERGING INFECTIOUS DISEASES, 1999, 5 (06) :757-765

[9] Molecular epidemiology survey of penicillin-susceptible and -resistant Streptococcus pneumoniae recovered from patients with meningitis in France [J].

Doit, C ;

Picard, B ;

Loukil, C ;

Geslin, P ;

Bingen, E .

JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (06) :1971-1978

[10]

GESLIN P, 1998, CTR NATL REFERENCE P